Problem & Opportunity
No FDA approved drugs
- Proven animal models for rapid screening
- Local delivery method improves outcomes with fewer off-target concerns
- Federal funding for initial studies
- Team of recognized experts across range of auditory maladies
Robust pipeline for science-based solutions to hearing disorders
We have developed animal model systems for pre-clinical trials of drug candidates and have advanced our leading drug candidate to a clinical Phase II trial with the US Army. NIH-supported research is now enabling us to move additional candidates through our discovery pipeline.
Prevalence of hearing loss and tinnitus in military population are greater than in the general public
Hearing loss is the most common work-related illness in the U.S.
Characterized by fluctuating hearing loss, often debilitating vertigo and roaring tinnitus that occurs in an episodic fashion. It’s estimated that there are 600,000-750,000 cases of Ménière’s disease in the United States.